Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1996;79:773-783

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naka, Y.
Right arrow Articles by Pinsky, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naka, Y.
Right arrow Articles by Pinsky, D. J.
(Circulation Research. 1996;79:773-783.)
© 1996 American Heart Association, Inc.


Articles

cAMP-Mediated Vascular Protection in an Orthotopic Rat Lung Transplant Model

Insights Into the Mechanism of Action of Prostaglandin E1 to Improve Lung Preservation

Yoshifumi Naka, Dilip K. Roy, Hui Liao, Nepal C. Chowdhury, Robert E. Michler, Mehmet C. Oz, David J. Pinsky

the Departments of Physiology (Y.N., H.L.), Surgery (D.K.R., N.C.C., R.E.M., M.C.O.), and Medicine (D.J.P.), Columbia University College of Physicians and Surgeons, New York, NY.

Correspondence to David J. Pinsky, MD, Columbia University, College of Physicians and Surgeons, Department of Medicine, PH 10-Stem, 630 W 168th St, New York, NY 10032. E-mail djp5@columbia.edu.

Prostaglandin E1 (PGE1) is often added to the donor pulmonary flush solution to enhance clinical lung preservation for transplantation. Although PGE1 is thought to act as a pulmonary vasodilator during the harvest period, the precise mechanism(s) of action whereby PGE1 enhances lung preservation is unknown. Because cAMP levels decline in endothelial and vascular smooth muscle cells exposed to hypoxia, we hypothesized that a PGE1-mediated increase in cAMP levels within the preserved lungs might improve pulmonary vascular homeostasis following lung transplantation. Rat lungs demonstrated a time-dependent decline in cAMP levels during hypothermic storage, with cAMP levels significantly increased by PGE1 supplementation ({approx}2-fold by 6 hours, P<.0005). To test whether augmenting cAMP levels may enhance lung preservation, experiments were performed using an orthotopic rat left lung transplant model. Compared with controls, supplementing the preservation solution with the membrane-permeable cAMP analogue dibutyryl-cAMP resulted in dose-dependent preservation enhancement, marked by reduced pulmonary vascular resistance (6.0-fold, P<.01), improved arterial oxygenation (3.0-fold, P<.01), reduced graft neutrophil infiltration (1.5-fold, P<.05), and improved recipient survival (7.0-fold, P<.005). Similar preservation enhancement was observed with another cAMP analogue (8-bromo-cAMP) or the phosphodiesterase inhibitor indolidan. Stimulating the cAMP second messenger system by PGE1 supplementation resulted in marked hemodynamic benefits and improved recipient survival, in parallel with reduced graft neutrophil infiltration, vascular permeability, and platelet deposition. These beneficial effects of PGE1 were abrogated by simultaneous administration of the cAMP-dependent protein kinase antagonist Rp-cAMPS. Although an arterial vasodilator (minoxidil) resulted in significant pulmonary vasodilation during harvest, it lacked other nonvasodilating effects of PGE1 and resulted in poor preservation. These data show that harvest vasodilation by itself is insufficient to enhance lung preservation and that PGE1 enhances lung preservation by stimulating the cAMP-dependent protein kinase and promoting nonvasodilatory mechanisms of pulmonary protection.


Key Words: cAMP • prostaglandin E1 • lung transplantation • protein kinase A • blood vessels




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
J. Cheng and J. P. Grande
Cyclic Nucleotide Phosphodiesterase (PDE) Inhibitors: Novel Therapeutic Agents for Progressive Renal Disease
Experimental Biology and Medicine, January 1, 2007; 232(1): 38 - 51.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. S. Wilkes, T. M. Egan, and H. Y. Reynolds
Lung Transplantation: Opportunities for Research and Clinical Advancement
Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 944 - 955.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. Gohrbandt, S. P. Sommer, S. Fischer, J. M. Hohlfeld, G. Warnecke, A. Haverich, and M. Strueber
Iloprost to improve surfactant function in porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution
J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 80 - 86.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Sakaguchi, T. Asai, D. Belov, M. Okada, D. J. Pinsky, A. M. Schmidt, and Y. Naka
Influence of ischemic injury on vein graft remodeling: Role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation
J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 129 - 137.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
A. Tierney, R. Foster, and D. Ogella
A perfusionist's role in lung transplant preservation
Perfusion, December 1, 2004; 19(6): 351 - 357.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee
Ischemia-Reperfusion-induced Lung Injury
Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 490 - 511.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
K. Minamoto, D. J. Pinsky, T. Fujita, and Y. Naka
Timing of Nitric Oxide Donor Supplementation Determines Endothelin-1 Regulation and Quality of Lung Preservation for Transplantation
Am. J. Respir. Cell Mol. Biol., January 1, 2002; 26(1): 14 - 21.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Sunose, I. Takeyoshi, H. Tsutsumi, S. Ohwada, N. Oriuchi, K. Matsumoto, and Y. Morishita
Effect of a cyclooxygenase-2 inhibitor, FK3311, in a canine lung transplantation model
Ann. Thorac. Surg., October 1, 2001; 72(4): 1165 - 1171.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
H. Schutte, A. Lockinger, W. Seeger, and F. Grimminger
Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion
Eur. Respir. J., July 1, 2001; 18(1): 15 - 22.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. L. FEATHERSTONE, D. J. CHAMBERS, and F. J. KELLY
Comparison of Phosphodiesterase Inhibitors of Differing Isoenzyme Selectivity Added to St. Thomas' Hospital Cardioplegic Solution Used for Hypothermic Preservation of Rat Lungs
Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 850 - 856.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
C. Y. Wang, I. Aronson, S. Takuma, S. Homma, Y. Naka, T. Alshafie, V. Brovkovych, T. Malinski, M. C. Oz, and D. J. Pinsky
cAMP Pulse During Preservation Inhibits the Late Development of Cardiac Isograft and Allograft Vasculopathy
Circ. Res., May 12, 2000; 86(9): 982 - 988.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. J. Pinsky and Y. Naka

Ann. Thorac. Surg., March 1, 2000; 69(3): 891 - 892.
[Full Text] [PDF]


Home page
Circ. Res.Home page
K. Toda, K. Kayano, A. Karimova, Y. Naka, T. Fujita, K. Minamoto, C. Y. Wang, and D. J. Pinsky
Antisense Intercellular Adhesion Molecule-1 (ICAM-1) Oligodeoxyribonucleotide Delivered During Organ Preservation Inhibits Posttransplant ICAM-1 Expression and Reduces Primary Lung Isograft Failure
Circ. Res., February 4, 2000; 86(2): 166 - 174.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Kayano, K. Toda, Y. Naka, and D. J. Pinsky
Identification of Optimal Conditions for Lung Graft Storage With Euro-Collins Solution by Use of a Rat Orthotopic Lung Transplant Model
Circulation, November 9, 1999; 100(90002): II-257 - 261.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Hillinger, R. A. Schmid, P. Sandera, U. Stammberger, D. Schneiter, G. Schoedon, and W. Weder
8-Br-cGMP is superior to prostaglandin e1 for lung preservation
Ann. Thorac. Surg., October 1, 1999; 68(4): 1138 - 1142.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C.-H. CHIANG, K. WU, C.-P. YU, H.-C. YAN, W.-C. PERNG, and C.-P. WU
Hypothermia and Prostaglandin E1 Produce Synergistic Attenuation of Ischemia-Reperfusion Lung Injury
Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1319 - 1323.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Kayano, K. Toda, Y. Naka, K. Okada, M. C. Oz, and D. J. Pinsky
SUPERIOR PROTECTION IN ORTHOTOPIC RAT LUNG TRANSPLANTATION WITHCYCLIC ADENOSINE MONOPHOSPHATE AND NITROGLYCERIN-CONTAINING PRESERVATIONSOLUTION
J. Thorac. Cardiovasc. Surg., July 1, 1999; 118(1): 135 - 144.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. B. Pearse, E. M. Wagner, and S. Permutt
Effect of ventilation on vascular permeability and cyclic nucleotide concentrations in ischemic sheep lungs
J Appl Physiol, January 1, 1999; 86(1): 123 - 132.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. J. Pinsky
Invited Commentary
Ann. Thorac. Surg., December 1, 1996; 62(6): 1586 - 1587.
[Full Text]